Record No:1


ACCESS NOD107247
GENE_NAMEFOXO3 
DESCRIPTIONForkhead box O3
ALIASESAF6q21, FKHRL1, FKHRL1P2, FOXO2, FOXO3A.
NCBI_ENTREZ_NO2309
UNIPROT_ACCESS_NOO43524
ORGANISMHuman
DISEASE_PHENOTYPEAsthma, COPD
SAMPLEPrimary Bronchial Epithelial Cells (BECs)
TECHNIQUESqRT-PCR
OMICSGenomics
STUDYLow Throughput
GEO_PRIDE_ACCESS_NONA
COMMENTSSignificantly decreased expression levels of FOXO3 was noted primary bronchial epthelial cells in asthmatics and COPD patients as compared to healthy subjects.
REFERENCE30696075
IMMUNITY_TERMNo
GO_MOLECULAR_FUNCTIONTranscription regulatory region sequence-specific DNA binding, RNA polymerase II proximal promoter sequence-specific DNA binding, DNA-binding transcription factor activity (RNA polymerase II-specific), transcription cofactor binding, DNA-binding transcription repressor activity (RNA polymerase II-specific), DNA-binding transcription activator activity (RNA polymerase II-specific), DNA binding, DNA-binding transcription factor activity, protein binding, beta-catenin binding, transcription factor binding, protein kinase binding, chromatin DNA binding, mitochondrial sequence-specific DNA-binding transcription factor activity, sequence-specific DNA binding.
GO_BIOLOGICAL_PROCESSNegative regulation of transcription by RNA polymerase II, ovulation from ovarian follicle, initiation of primordial ovarian follicle growth, antral ovarian follicle growth, oocyte maturation, regulation of DNA-templated transcription, regulation of transcription by RNA polymerase II, mitochondrial transcription, regulation of translation, apoptotic process, aging, insulin receptor signaling pathway, positive regulation of autophagy, positive regulation of muscle atrophy, cytokine-mediated signaling pathway, DNA damage response (signal transduction by p53 class mediator), negative regulation of cell migration, response to nutrient levels, tumor necrosis factor-mediated signaling pathway, cellular response to oxidative stress, cellular response to glucose starvation, response to drug, glucose homeostasis, response to starvation, positive regulation of apoptotic process, positive regulation of neuron apoptotic process, positive regulation of erythrocyte differentiation, negative regulation of neuron differentiation, positive regulation of DNA-templated transcription, positive regulation of transcription by RNA polymerase II, brain morphogenesis, response to fatty acid, cellular response to glucose stimulus, cellular response to corticosterone stimulus, cellular response to hypoxia, response to dexamethasone, negative regulation of canonical Wnt signaling pathway, neuronal stem cell population maintenance, extrinsic apoptotic signaling pathway in absence of ligand, positive regulation of hydrogen peroxide-mediated programmed cell death, positive regulation of pri-miRNA transcription by RNA polymerase II, positive regulation of reactive oxygen species biosynthetic process, cellular response to amyloid-beta, cellular response to nerve growth factor stimulus, response to water-immersion restraint stress, regulation of neural precursor cell proliferation, positive regulation of endothelial cell apoptotic process, regulation of reactive oxygen species metabolic process.
BIOGRID_INTERACTION_ID108598
SNP_ID300253
DRUG_ID-
STRUCTURE_ID209372
209373
209374
209375
209376
MONOCLONAL_ANTIBODYAnti-FOXO3A antibody for Human, Rat; Anti-FOXO3A (phospho S253) antibody for Human, Mouse, Rat.